Seoul, 8–10 November 2026
Dr. Hernán Pinto presented the MCT System and its photothermal biomodulation technology in Seoul, alongside five Korean plastic surgeons who shared their clinical experience.
Meta Cell Technology (MCT) took part in PRS Korea 2026 with a lecture in the main scientific programme, a dedicated scientific session on clinical applications and a stand in the congress exhibition.
Dr. Hernán Pinto (second from right) with the Korean plastic surgeons who presented in the MCT scientific session at PRS Korea 2026, Grand InterContinental Seoul Parnas.
SEOUL, South Korea – 10 November 2026 – Meta Cell Technology (MCT) has taken part in PRS Korea 2026, the annual congress of the Korean Society of Plastic and Reconstructive Surgeons, held from 8 to 10 November at the Grand InterContinental Seoul Parnas. This year’s edition celebrated the 60th anniversary of the Society under the theme “A 60-Year Legacy, Shaping the Future”.
MCT’s participation was led by Dr. Hernán Pinto, Chief Scientific Officer and Co-founder of Meta Cell Technology, who travelled from Barcelona to join MCT’s team in Korea and a group of Korean plastic surgeons who use the technology in their clinical practice.
Dr. Hernán Pinto (centre) on stage at PRS Korea 2026, the 60th anniversary congress of the Korean Society of Plastic and Reconstructive Surgeons, Grand InterContinental Seoul Parnas.
Photothermal biomodulation in the scientific programme
On Sunday 8 November, Dr. Pinto delivered a lecture on photothermal biomodulation in the main scientific programme. He outlined the principles behind the technology, which applies specific wavelengths of light and controlled temperature to the patient’s own biological material at the point of care, and the scientific rationale on which its use is based.
Earlier that morning, in the same room, Dr. Ye Seul Moon of Wannabe Plastic Surgery compared injectable products with autologous approaches based on light and temperature, and the clinical criteria that guide the choice between them in plastic surgery.
Dr. Hernán Pinto during his lecture on photothermal biomodulation.
Dr. Ye Seul Moon (Wannabe Plastic Surgery) and Dr. Hernán Pinto before her lecture in Room 2.
A dedicated session on clinical applications
In the afternoon, MCT held a dedicated scientific session in Room 7. Dr. Pinto opened it with an overview of the scientific background and recommended use of the MCT System, followed by four Korean plastic surgeons who shared how they work with it in their own practice:
- Dr. Young Jae Lee (Sinsang Plastic Surgery) explained how he approaches scar tissue and adhesions when a patient needs revision surgery.
- Dr. Dae Myung Oh (Cellup Plastic Surgery) described the role of the technology in his tissue regeneration procedures.
- Dr. Jang Won Lee (Balance Lab Plastic Surgery) presented how he combines MCT with minimally invasive procedures.
- Dr. Jino Kim (New Hair Plastic Surgery) focused on hair loss and the environment that surrounds the hair follicle.
The session closed with a panel discussion with all the speakers. Throughout the congress, MCT also welcomed physicians at its stand in the exhibition area (Booth 52).
The MCT scientific session in Room 7, with presentations by Dr. Young Jae Lee (left) and Dr. Jang Won Lee (right).
“Plastic and reconstructive surgery is one of the specialties where autologous approaches are being discussed most actively. What we value most in Seoul is hearing surgeons present their own protocols and their own cases: that is how clinical knowledge around a technology grows, and it is the kind of exchange MCT wants to support in every market.”
Dr. Hernán Pinto, Chief Scientific Officer and Co-founder, Meta Cell Technology
Growth built with the medical community
Meta Cell Technology’s international development has been built in close collaboration with the medical community. With a presence in more than 60 countries, the company works alongside healthcare professionals whose clinical experience and scientific contributions continue to advance the understanding and application of photothermal biomodulation. MCT’s participation in PRS Korea 2026 reflects this commitment to scientific exchange and to supporting physicians in each of the markets where it operates.
MCT extends its gratitude to the Korean Society of Plastic and Reconstructive Surgeons, to Dr. Jino Kim, Dr. Young Jae Lee, Dr. Jang Won Lee, Dr. Dae Myung Oh and Dr. Ye Seul Moon for their contributions, and to its team in Korea for coordinating the company’s participation in the congress.
ABOUT META CELL TECHNOLOGY
Meta Cell Technology is a Barcelona-based medical technology company focused on technologies for the conditioning of autologous biological material through photothermal biomodulation. The company works internationally through a network of distribution partners and healthcare professionals, complementing technology development with research, evidence generation and medical education. Its portfolio includes CE-marked medical devices, and the company operates under an ISO 13485-certified quality management system.
MEDIA CONTACT
Sherry Cacay Llanes
Marketing Manager, Meta Cell Technology
globalmarketing@clinipro.net
